Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaus Wolff

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Cancer Research|December 26, 2003
An endogenous retrovirus derived from human melanoma cellsThomas Muster, Andrea Waltenberger, Andreas Grassauer, et al.
The Journal of Investigative Dermatology|October 31, 2002
Pimecrolimus identifies a common genomic anti-inflammatory profile, is clinically highly effective in psoriasis and is well toleratedKlemens Rappersberger, Michael Komar, Marie-Eve Ebelin, et al.
American Journal of Clinical Dermatology|April 12, 2006
Safety, efficacy, and dosage of 1% pimecrolimus cream for the treatment of atopic dermatitis in daily practiceJann Lübbe, Sheila F Friedlander, Bernard Cribier, et al.
Wiener Klinische Wochenschrift|June 9, 2005
The European Competence Network on Mastocytosis (ECNM)Peter Valent, Michel Arock, Stephan C Bischoff, et al.
Journal of the American Academy of Dermatology|May 8, 2003
Dermoscopy of pigmented skin lesions: results of a consensus meeting via the InternetGiuseppe Argenziano, H Peter Soyer, Sergio Chimenti, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Cancer Research|December 26, 2003
An endogenous retrovirus derived from human melanoma cellsThomas Muster, Andrea Waltenberger, Andreas Grassauer, et al.
The Journal of Investigative Dermatology|October 31, 2002
Pimecrolimus identifies a common genomic anti-inflammatory profile, is clinically highly effective in psoriasis and is well toleratedKlemens Rappersberger, Michael Komar, Marie-Eve Ebelin, et al.
American Journal of Clinical Dermatology|April 12, 2006
Safety, efficacy, and dosage of 1% pimecrolimus cream for the treatment of atopic dermatitis in daily practiceJann Lübbe, Sheila F Friedlander, Bernard Cribier, et al.
Wiener Klinische Wochenschrift|June 9, 2005
The European Competence Network on Mastocytosis (ECNM)Peter Valent, Michel Arock, Stephan C Bischoff, et al.
Journal of the American Academy of Dermatology|May 8, 2003
Dermoscopy of pigmented skin lesions: results of a consensus meeting via the InternetGiuseppe Argenziano, H Peter Soyer, Sergio Chimenti, et al.
Pageof 6